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Background/aim: The aims of this study were to investigate the significance of oxidative stress parameters in the pathogenesis of
ischemic stroke and hemorrhagic stroke and to investigate their effects on stroke severity using the National Institutes of Health Stroke
Scale (NIHSS).
Materials and methods: A total of 92 patients, including 74 with ischemic stroke and 18 with hemorrhagic stroke, and 75 volunteers
were enrolled in the study. Total oxidant status (TOS), total antioxidant status (TAS), paraoxonase, stimulating paraoxonase, arylesterase,
and thiol levels were measured in both the patient and volunteer groups. NIHSS and oxidative stress index (OSI) scores were calculated.
Results: TOS and OSI levels were significantly higher in the ischemia and hemorrhagic stroke groups than in the control group (P
< 0.05). Arylesterase and thiol levels were significantly lower in the ischemia group than the control group (P < 0.05). No significant
correlation was found between NIHSS score and TAS, TOS, OSI, paraoxonase, arylesterase, stimulated paraoxonase, and thiol levels (P
> 0.05).
Conclusion: Oxidative stress may play a role in the pathogenesis of both ischemic stroke and hemorrhagic stroke in terms of oxidants.
We do not think that oxidative stress has any effect in determining stroke severity in either type of stroke.
Key words: Oxidative stress, ischemic stroke, hemorrhagic stroke, National Institutes of Health Stroke Scale

1. Introduction
Stroke is a medical emergency situation that may cause
loss of brain function and even death. This condition is
the second most common cause of death and the most
common cause of impairment among adults in the West
(1). Strokes are classified into two groups according to
their pathology: ischemic stroke and hemorrhagic stroke.
Ischemic strokes make up 87% and hemorrhagic strokes
13% of all strokes (2).
Electron acceptor molecules in biological systems
are known as free oxygen radicals (3). Active oxygen
derivatives of free radicals are referred to as oxidants.
Oxidants change the structure and function of target
molecules by receiving electrons from them. Oxidants
also affect cell membranes and genetic material such as
DNA, RNA, and various enzymatic events, and they lead
to cell damage during ischemia and reperfusion. Various
antioxidants protect the organism from the harmful effects
* Correspondence: ferhaticme@gmail.com

of oxidants by destroying them (4). In the organism,
imbalance between the oxidant and antioxidant systems
caused by production of excessive amounts of free oxygen
radicals or insufficient antioxidants is called oxidative
stress (4). Oxidative stress has been shown to play a role
in the occurrence and progression of many local and
systemic diseases.
Experimental and clinical studies suggest that oxidative
stress plays an important role in brain injury that follows
a stroke (5,6). However, although the effect of free oxygen
radicals in the process is well-known, the role of antioxidant
mechanisms has not been clarified (7). There are very
few studies investigating the effects of oxidative stress in
hemorrhagic stroke (8). The aims of this study were to
investigate the significance of oxidative stress parameters
in the pathogenesis of ischemic and hemorrhagic stroke
and to investigate their effects on stroke severity using the
National Institutes of Health Stroke Scale (NIHSS).
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2. Materials and methods
2.1. Patients
This study was conducted in the Ankara Atatürk Training
and Research Hospital emergency service between January
and November 2013, after receiving approval from the
ethics committee and informed consent from the patients
or their first-degree relatives.
The study group included a total of 92 patients, who
were diagnosed with stroke according to World Health
Organization criteria. Seventy-four patients had ischemic
stroke and 18 had hemorrhagic stroke (nontraumatic
subarachnoid hemorrhage and intraparenchymal
hemorrhage). The control group included 75 healthy
volunteers who were not suspected of having stroke or
transient ischemic attack and did not have any of the
exclusion criteria.
All patients underwent detailed neurological
examinations to determine their level of awareness;
cerebral tomography was completed. Immediately after
the diagnoses were confirmed by cerebral tomography
and neurological examination, the NIHSS score was
calculated, and blood samples were taken for examining
total oxidant status (TOS), total antioxidant status (TAS),
paraoxonase, stimulated paraoxonase, arylesterase, and
thiol. Blood samples were taken from the control group in
order to study the same oxidative stress parameters. The
samples were centrifuged at 3000 rpm for 5 min and stored
at –80 °C in a deep freezer. All samples were dissolved and
analyzed simultaneously during the study.
Patient cards included demographical data (age,
sex), duration between onset of symptoms and hospital
admission, symptoms and physical examination findings
on admission, additional diseases, and habits (alcohol,
tobacco). NIHSS scores were calculated according to the
modification of Meyer et al. (9).
2.2. Exclusion criteria
Patients were excluded from the study on the basis of the
following criteria: delay of more than 24 h between onset
of symptoms and diagnosis of stroke; no bleeding area or
infarct identified in the tomography taken on admission to
the emergency room; bleeding or infarcts due to reasons
such as trauma, tumor, or infection; lacunar infarct; and
pulmonary (chronic obstructive and restrictive lung
disease, lung cancer, collagen vascular disease, etc.), liver,
or kidney diseases.
2.3. Limitations of the study
Although its proportion was representative of the number
of hemorrhagic stroke patients in the population, the
hemorrhagic stroke group in our study was small.
Moreover,
infarct volume, which has a prognostic value in
ischemic stroke, was not calculated.
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2.4. Methods
2.4.1. Determination of serum TAS levels
TAS levels were measured using commercially available
kits (Rel Assay, Turkey). The novel automated method
is based on the bleaching of the characteristic color of a
more stable ABTS [2,2-azinobis(3-ethylbenzothiazoline6-sulfonic acid)] radical cation by antioxidants. The assay
has excellent precision values that are lower than 3%. The
results were expressed as mmol Trolox equivalent/L (10).
2.4.2. Determination of serum TOS levels
TOS levels were measured using commercially available
kits (Rel Assay, Turkey). With the new method, the
oxidants present in the sample oxidized the ferrous
ion-o-dianisidine complex to ferric ion. The oxidation
reaction was enhanced by glycerol molecules abundantly
present in the reaction medium. The ferric ion produced
a colored complex with xylenol orange in an acidic
medium. Color intensity, which could be measured
spectrophotometrically, was related to the total amount
of oxidant molecules present in the sample. The assay was
calibrated with hydrogen peroxide and the results were
expressed in terms of micromolar hydrogen peroxide
equivalent per liter (mol H2O2 equivalent/L) (11).
2.4.3. Calculation of OSI
OSI is calculated by dividing TOS by TAS, and a higher
index indicates increased oxidative stress (12,13).
2.4.4. Measurement of plasma levels of thiol
Plasma thiol levels were defined by measuring the color
intensity of dark yellow-colored 5-thio-2-nitrobenzoic
acid (TNB), which is produced during the oxidation
of free thiol groups with Ellman reagent [5,5’-dithiobis
(2-nitrobenzoic acid), DTNB] at a wavelength of 412 nm
(14).
2.4.5. Measurement of paraoxonase, stimulated
paraoxonase, and arylesterase activities
Paraoxonase activity was determined using paraoxon as
a substrate and was measured by increases in absorbance
at 412 nm due to the formation of 4-nitrophenol, as
described previously (15). The activity was measured at 25
°C by adding 50 μL of serum to 1 mL of Tris-HCl buffer
(100 mM at PH 8.0) containing 2 mM CaCl2 and 5 mM
paraoxon. The rate of generation of 4-nitrophenol was
determined at 412 nm. Enzymatic activity was calculated
by using molar extinction coefficient 17,100 M–1 cm–1.
Arylesterase activity was measured using phenyl acetate as
a substrate. The serum was diluted 400 times in 100 mM
Tris-HCl buffer, pH 8.0. The reaction mixture contained
2.0 mM phenyl acetate (Sigma Chemical Co.) and 2.0 mM
CaCl2 in 100 mM Tris-HCl buffer, pH 8.0. Initial rates of
hydrolysis were determined by following the increase of
phenol concentration at 270 nm at 37 °C on a CE 7250
spectrophotometer (Cecil Instruments, UK) (16). Enzyme
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2). According to patients’ history, 18 patients (20%)
were smokers and 2 patients (2%) consumed alcohol.
Regarding patients’ medical history, 59 patients (64%) had
hypertension (HT), 29 patients (32%) had atherosclerotic
heart disease, 24 patients (26%) had diabetes mellitus,
17 patients (18%) had previous cerebrovascular disease
(CVD), 13 patients (14%) had arrhythmia, and 26 patients
(28%) had other comorbidities (Table 2).
TOS and OSI values were significantly higher in
the patient group than in the control group (P < 0.05).
Arylesterase and thiol values were significantly lower in
the patient group than the control group (P < 0.05). TAS,
stimulated paraoxonase, and paraoxonase levels did not
differ significantly among the groups (P > 0.05) (Table 3).
There was a negative correlation between NIHSS score
and admission period (P < 0.05). There were no significant
correlations between NIHSS score and TAS, TOS, OSI,
paraoxonase, arylesterase, stimulated paraoxonase, and
thiol values (P > 0.05) (Table 4).
There were no significant correlations between
admission period and TAS, TOS, OSI, paraoxonase,
arylesterase, stimulated paraoxonase, and thiol values (P
> 0.05) (Table 4).

activities were expressed in international units (U) or
kilounits (kU) per 1 L of sera.
2.5. Statistical analysis
Data from descriptive statistics were analyzed using
mean, standard deviation, rate, and frequency values. The
distribution of variables was checked for normality with
the Kolmogorov–Smirnov test. The Mann–Whitney U test
and independent samples t-test were used in the analysis
of quantitative data. The chi-square test was used in the
analysis of qualitative data. Spearman’s rho correlation
was used for correlation analyses. SPSS 21.0 was used for
statistical analysis.
3. Results
Age and sex did not differ between the patient groups and
the control group (P > 0.05) (Table 1).
The number of patients brought by ambulances was 47
(51%) and the number of patients arriving at the emergency
department by their own transportation was 45 (49%)
(Table 2). The most common complaints on admission
were weakness (n = 66, 66%), loss of consciousness (n =
25, 27%), speech difficulty (n = 20, 22%), numbness (n
= 11, 12%), and fatigue (n = 1, 1%), respectively (Table

Table 1. Demographic data of the patient and control groups.
Patient group

Control group

Mean ± SD / n %
Age
Sex

P

Mean ±SD / n %

71.80 ± 12.33

72.36 ± 6.10

Female

47

51

38

51

Male

45

49

37

49

0.705
0.957

Independent samples t-test/chi-square test.
Table 2. Characteristics of the patient group.

Type of arrival

On admission

n

%

With ambulance

47

51

Smoking

18

20

Outpatients

45

49

Alcohol use

2

2

Loss of consciousness

25

27

DM

24

26

Loss of strength

66

72

HT

59

64

Weakness

1

1

CVD

17

18

Numbness

11

12

CHD

29

32

Speech impairment

20

22

Arrhythmia

13

14

Other

26

Admission time (mean ± SD)
Type

8.03

n

Add.
disease

± 5.95

Ischemia

74

80

Hemorrhage

18

20

NIHSS

6.61

%

28
± 6.90
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Table 3. Patient groups and control group were compared in terms of oxidative stress parameters.
Patient group

Control group

Mean ± SD

Mean ± SD

TAS

2.32 ± 0.65

2.34 ± 0.30

P
0.326

TOS

2.86 ± 1.86

2.10 ± 1.58

0.005

OSI

1.26 ± 0.82

0.91 ± 0.70

0.004

Paraoxonase

132.23 ± 78.95

150.77 ± 89.00

0.276

St. paraoxonase

343.64 ± 217.13

389.35 ± 250.69

0.401

Arylesterase

138.17 ± 58.89

180.96 ± 62.90

0.001

Thiol

122.77 ± 47.38

151.03 ± 40.78

0.001

Independent samples t-test / Mann–Whitney U test.
Table 4. Admission period and oxidative stress parameters compared to NIHSS.
Admission time
(hours)
Admission time
(hours)
NIHSS

r
P

-

TAS

TOS

OSI

PON

St. PON

ARE

Thiol

0.022

–0.086

–0.107

0.128

0.134

–0.004

0.048

0.832

0.413

0.311

0.223

0.202

0.970

0.648

r

–0.257

–0.075

0.109

0.130

–0.143

–0.132

–0.102

–0.164

P

0.003

0.476

0.303

0.218

0.173

0.211

0.334

0.118

Spearman–Pearson correlation.

There were no significant differences between the
subgroups of patients with ischemia and bleeding in
NIHSS, TAS, TOS, OSI, arylesterase, thiol, paraoxonase,
and stimulated paraoxonase values (P > 0.05) (Table 5).
There were no significant differences between the
patients with ischemic stroke and the control group in
terms of TAS, paraoxonase, and stimulated paraoxonase
values (P > 0.05). TOS and OSI values were significantly
higher in the ischemia group than in the control group (P
< 0.05). Arylesterase and thiol values were significantly
lower in the ischemia group than in the control group (P
< 0.05) (Table 5).
TAS,
paraoxonase,
stimulated
paraoxonase,
arylesterase, and thiol values did not differ significantly
between the hemorrhagic stroke patients and the control
group (P > 0.05). TOS and OSI values were significantly
higher in the hemorrhagic stroke patients than in the
control group (P < 0.05) (Table 5).
4. Discussion
Since it has been shown that oxidative stress parameters
were effective in the occurrence, progression, and
complications of many local and systemic diseases, a
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number of studies on oxidative stress parameters have
been conducted. Although oxidant and antioxidant levels
in stroke patients have been widely studied, their role,
especially in pathogenesis, is still controversial. In addition,
there are significantly fewer studies on hemorrhagic stroke
patients than on ischemic stroke patients; studies dealing
with and comparing both of these groups are extremely
limited (7,8). In our study, we investigated oxidative stress
parameters in both ischemic stroke and hemorrhagic
stroke patients. According to the results of our study,
TOS and OSI levels were increased in both ischemic and
hemorrhagic stroke. In hemorrhagic stroke, the total
antioxidant level and other antioxidant levels did not
change significantly, whereas thiol and arylesterase levels
were higher in ischemic stroke. No change was detected in
total antioxidant and other antioxidant levels.
Parizadeh et al. showed that the prooxidant/antioxidant
balance increased in the serum of patients with stroke;
however, there was no difference between the ischemic and
hemorrhagic stroke subgroups. Additionally, they showed
that oxidative parameters were not useful in predicting
the 6-month prognosis (7). In another study it was shown
that TOS levels increased in the serum of patients with
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Table 5. Comparison of hemorrhagic stroke, ischemic stroke, and control groups in terms oxidative stress parameters.
Ischemia

Hemorrhage

Control

Isc-Hem

Isc-Cont

Hem-Cont

Mean ± SD

Mean ± SD

Mean ± SD

P

P

P

NIHSS
Admission
time
TAS

8.15 ± 5.93

7.56 ± 6.16

-

-

0.671

-

-

6.81 ± 6.83

5.78 ± 7.34

-

-

0.256

-

-

2.35 ± 0.71

2.21 ± 0.23

2.34 ± 0.30

0.598

0.492

0.104

TOS

2.81 ± 1.93

3.07 ± 1.55

2.10 ± 1.58

0.558

0.015

0.021

OSI

1.25 ± 0.85

1.31 ± 0.70

0.91 ± 0.70

0.779

0.009

0.032

Paraoxonase

134.3 ± 78.90

123.76 ± 80.89

150.77 ± 89.0

0.448

0.412

0.243

Stimulated paraoxonase

347.5 ± 215.8

327.37 ± 227.8

389.35 ± 250.6

0.506

0.506

0.403

Arylesterase

132.2 ± 48.86

162.52 ± 86.80

180.96 ± 62.90

0.169

0.001

0.304

Thiol

122.6 ± 41.33

123.30 ± 68.41

151.03 ± 40.78

0.969

0.001

0.114

Independent samples t-test / Mann–Whitney U-test.

hemorrhagic stroke in the acute phase. Nevertheless,
there was no significant correlation between TOS, total
hematoma volume, and Glasgow Coma Scale (GCS) score
(8). Kotan et al. showed that OSI and infarct volume were
correlated, and they suggested that oxidative stress plays
a role in the pathogenesis of ischemic stroke (17). Aygul
et al. also suggested that oxidative stress was involved in
the pathogenesis of ischemic stroke (18). In our study,
TOS and OSI levels were significantly higher in all stroke
patients, both with ischemic stroke and hemorrhagic
stroke, than in the control group. There was no difference
between the ischemic stroke and hemorrhagic stroke
subgroups. There was no significant difference between
NIHSS score, which is an important indicator of stroke
severity, and TOS and OSI in either stroke groups. In light
of the present findings, we think that oxidants formed
before or during ischemia might damage neurons in both
ischemic stroke and hemorrhagic stroke and may play a
role in their pathophysiology. Nevertheless, oxidant levels
are not suitable for determining stroke severity.
TAS level indicates the level of total antioxidants in
the body; therefore, it better reflects whether oxidative
stress is caused by excess antioxidants. This measure
is more suitable than measuring individual substances
with antioxidant properties (19). Çevik et al. found that
malondialdehyde and TAS increased in the plasma of
patients with hemorrhagic stroke in the acute phase,
but these measures were not correlated with GCS. They
suggested that although antioxidants play a role in the
pathogenesis of hemorrhagic stroke, oxidative stress
markers do not have any effect on the severity of stroke
(8). Similarly, Aygul et al. did not find any correlation
between oxidative stress parameters and GCS in their

study (20). In another study examining antioxidant
ascorbic acid, a positive correlation with GCS score and
a negative correlation with the volume of the hematoma
were reported (21). Once more, Leinonen et al. reported
a significant relationship between total plasma peroxyl
radical-trapping potential, which they accepted to be
TAS. In addition, they measured and calculated TAS
and NIHSS in a different way than in this study (22).
Lagowska-Lenard et al. found a reduction in TAS in stroke
patients when compared to the control group (23). Other
studies also reported a decrease in TAS levels in ischemic
stroke, whereas Sheikh et al. reported no change in TAS
levels in patients with ischemic stroke (24–26). In our
study, TAS levels did not change significantly, neither in
the hemorrhagic nor in the ischemic stroke group, and
there was no correlation between TAS and NIHSS scores.
On the basis of these results, we suggest that oxidative
stress that is in equilibrium in the acute phases of both
ischemic and hemorrhagic strokes becomes unbalanced
due to an increased oxidant level rather than a decreased
antioxidant level; therefore, antioxidants do not have a role
in the pathogenesis of stroke. In addition, the absence of a
statistically significant relationship between NIHSS score
and TAS suggests that antioxidant levels are not effective
in determining stroke severity.
Paraoxonase is an enzyme that exists in the structure
of HDL cholesterol and inhibits lipoprotein oxidation
by hydrolyzing lipid peroxides in oxidized LDL. The
paraoxonase enzyme, which exists within circulating
HDL, inhibits LDL oxidation by inhibiting the release
of superoxide anion from macrophages and reduces the
formation of oxidized LDL. Thus, inflammatory processes
that are induced by oxidized LDL in endothelial cells are
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avoided (27). Several studies investigating the relationship
between stroke and paraoxonase levels in ischemic stroke
reported varying results, depending on the society in which
the study was conducted. However, in almost all of these
studies no correlation between paraoxonase levels and
hemorrhagic stroke was found (25,28–30). In addition,
Acer et al. did not find any correlation between paraoxonase
and NIHSS in their study of ischemic stroke, although they
discovered a negative correlation between TAS and NIHSS
(25). In our study, paraoxonase levels showed no significant
changes in the hemorrhagic or ischemic stroke groups.
We suggest that the varying results in our study and other
studies depend on polymorphic differences of paraoxonase
enzyme activity with respect to individuals.
Paraoxonase activity may be stimulated by NaCl, and as
a result stimulated paraoxonase is produced (31). Although
the significance of paraoxonase activity stimulated by
NaCl is not clearly understood, it is used in detecting the
paraoxonase-1 phenotype (32). Two types of paraoxonase
phenotype, A and B, have been identified in the studies
conducted after it was understood that the paraoxonase-1
and arylesterase activities of the paraoxonase enzyme change
under different pH and salt concentrations. Phenotype
B, which is responsive to NaCl stimulation, has a high
enzyme activity against paraoxonase, whereas arylesterase
activity decreases with NaCl stimulation (32). In our study,
stimulated paraoxonase levels, in parallel with paraoxonase
levels, did not change significantly in either group.
Arylesterase is an antioxidant enzyme coded by the
same gene as paraoxonase; however, unlike paraoxonase,
it does not show genetic polymorphism. Measurements
of oxidative stress in many systemic diseases have
revealed a very significant correlation between serum
levels of arylesterase and these diseases (33). In our
study, arylesterase levels were significantly lower in the
ischemic stroke group, whereas no significant change in
hemorrhagic stroke was observed.

The term ‘thiol’ represents compounds containing
sulfur (-SH) groups. Plasma thiols have prooxidant or
antioxidant effects on physiological events, but they are
generally considered to be antioxidants (34,35). Plasma
thiol includes cysteine as the largest compound, followed by
homocysteine and glutathione, respectively. It is accepted
that the -SH group in thiols is protective against oxidative
stress. Prooxidant effects induced by thiol compounds have
been reported in renal ischemia, liver failure, and diseases
of cardiovascular and cerebrovascular tissues (36,37). In
their study, Leinonen et al. found a significant correlation
between thiol levels and NIHSS. However, Musumeci et al.
did not find any correlation between NIHSS and the SH
groups (22,38).
In our study, thiol levels in ischemic stroke patients
were significantly lower than in the control group, whereas
they did not change in patients with hemorrhagic stroke.
According to these results, thiol levels may be involved in
the pathogenesis of ischemic stroke but not in hemorrhagic
stroke. Due to the lack of any correlation between oxidative
stress parameters and NIHSS for either type of stroke, we
suggest that it is not useful in predicting prognosis.
Based on the finding of higher TOS and OSI values,
we suggest that oxidative stress is in the direction of
oxidation in the pathogenesis of both ischemic stroke and
hemorrhagic stroke. Because the TAS and other antioxidant
levels we studied showed no significant changes, we suggest
that antioxidants do not play a role in the pathogenesis of
hemorrhagic stroke. In ischemic stroke, TAS, paraoxonase,
and stimulated paraoxonase levels showed no significant
change, although thiol and arylesterase levels showed a
significant decrease. Therefore, we suggest that they play
a partial role in pathogenesis. Finally, due to the lack of
any correlation between oxidative stress parameters and
NIHSS for either type of stroke, we suggest that oxidative
stress parameters have no role in determining stroke
severity.
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